Citadel Advisors
CVRX icon

Citadel Advisors’s CVRx CVRX Stock Holding History

Citadel Advisors’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,800
Closed -$149K – 13864
2026
Q1 		$149K Buy
+15,800
New +$116K ﹤0.01% 11685
2025
Q4 		– Sell
-30,300
Closed -$245K – 12854
2025
Q3 		$245K Sell
30,300
-2,100
-6% -$15.8K ﹤0.01% 10808
2025
Q2 		$191K Buy
32,400
+12,400
+62% +$85.5K ﹤0.01% 10719
2025
Q1 		$245K Buy
20,000
+13,700
+217% +$193K ﹤0.01% 10038
2024
Q4 		$79.8K Sell
6,300
-20,600
-77% -$254K ﹤0.01% 11788
2024
Q3 		$237K Buy
26,900
+24,800
+1,181% +$226K ﹤0.01% 9802
2024
Q2 		$25.2K Sell
2,100
-11,800
-85% -$136K ﹤0.01% 12431
2024
Q1 		$253K Buy
13,900
+3,500
+34% +$82.9K ﹤0.01% 9837
2023
Q4 		$327K Sell
10,400
-24,700
-70% -$463K ﹤0.01% 9001
2023
Q3 		$532K Buy
35,100
+24,800
+241% +$408K ﹤0.01% 7927
2023
Q2 		$159K Sell
10,300
-6,200
-38% -$75.7K ﹤0.01% 10245
2023
Q1 		$154K Buy
16,500
+13,800
+511% +$183K ﹤0.01% 10599
2022
Q4 		$49.5K Buy
+2,700
New +$33.3K ﹤0.01% 12149
2022
Q3 		– Sell
-10,100
Closed -$61K – 12765
2022
Q2 		$61K Buy
+10,100
New +$58.1K ﹤0.01% 11805

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors's CVRX Position: Q2 2026 in Review

Citadel Advisors increased its CVRx (CVRX) stake by 197% in Q2 2026, buying an estimated $338K and bringing the position to 79,013 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #10384.

Citadel Advisors first reported a position in CVRX in Q2 2021 and has held it in 15 quarters since. The position peaked at $3.12M in Q1 2025. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • Citadel Advisors held 79,013 shares of CVRx worth $406K as of Q2 2026.
  • Citadel Advisors bought 52,386 CVRx shares in Q2 2026, an estimated $338K.
  • CVRx made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10384 holding.
  • Citadel Advisors first reported a position in CVRx in Q2 2021 and has held it in 15 quarters since.
  • Citadel Advisors's CVRx position peaked at $3.12M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.